相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High throughput screening technologies for ion channels
Hai-bo Yu et al.
ACTA PHARMACOLOGICA SINICA (2016)
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair
Matthew E. Hartman et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
Nicole T. Feric et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function
Ron Feiner et al.
NATURE MATERIALS (2016)
OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology
Aleksandra Klimas et al.
NATURE COMMUNICATIONS (2016)
High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes
Fabian Alexander Grimm et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)
Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro - Correlation between contraction force and electrophysiology
Marcelo C. Ribeiro et al.
BIOMATERIALS (2015)
A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents
Ilka Maschmeyer et al.
LAB ON A CHIP (2015)
ERBB2 triggers mammalian heart regeneration by promoting cardiorlyocyte dedifferentiation and proliferation
Gabriele D'Uva et al.
NATURE CELL BIOLOGY (2015)
2014 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2015)
Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?
Tulay Kus et al.
ONCOTARGETS AND THERAPY (2015)
Printable elastic conductors with a high conductivity for electronic textile applications
Naoji Matsuhisa et al.
NATURE COMMUNICATIONS (2015)
Advances in tissue engineering through stem cell-based co-culture
Nikolaos K. Paschos et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2015)
μOrgano: A Lego®-Like Plug & Play System for Modular Multi-Organ-Chips
Peter Loskill et al.
PLOS ONE (2015)
Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Amy Pointon et al.
TOXICOLOGICAL SCIENCES (2015)
The GSK-3 Family as Therapeutic Target for Myocardial Diseases
Hind Lal et al.
CIRCULATION RESEARCH (2015)
Engineering Adolescence Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Xiulan Yang et al.
CIRCULATION RESEARCH (2014)
Organs-on-a-chip: a new tool for drug discovery
Alessandro Polini et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Tri-iodo-L-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells
Xiulan Yang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Cardiac optogenetics
Emilia Entcheva
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes
Donghui Zhang et al.
BIOMATERIALS (2013)
Dynamic transcription factor activity profiling in 2D and 3D cell cultures
Abigail D. Bellis et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
Drug Screening Using a Library of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity
Ping Liang et al.
CIRCULATION (2013)
Engineering Challenges for Instrumenting and Controlling Integrated Organ-on-Chip Systems
John P. Wikswo et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2013)
On being the right size: scaling effects in designing a human-on-a-chip
Christopher Moraes et al.
INTEGRATIVE BIOLOGY (2013)
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes
Sara S. Nunes et al.
NATURE METHODS (2013)
Phase II and Phase III attrition rates 2011-2012
John Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues
Nimalan Thavandiran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem CellDerived Cardiomyocytes to Functional Preclinical Safety Assays
Kate Harris et al.
TOXICOLOGICAL SCIENCES (2013)
HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease
Gordana Vunjak-Novakovic et al.
STEM CELL RESEARCH & THERAPY (2013)
In vitro models for liver toxicity testing
Valerie Y. Soldatow et al.
TOXICOLOGY RESEARCH (2013)
Multiparameter In Vitro Assessment of Compound Effects on Cardiomyocyte Physiology Using iPSC Cells
Oksana Sirenko et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Clinical cardiac safety profile of nilotinib
Theo D. Kim et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
Erin J. Aiello Bowles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Macroporous nanowire nanoelectronic scaffolds for synthetic tissues
Bozhi Tian et al.
NATURE MATERIALS (2012)
Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads
Partho P. Sengupta et al.
MAYO CLINIC PROCEEDINGS (2012)
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
Junyi Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
The Role of Body-on-a-Chip Devices in Drug and Toxicity Studies
M. B. Esch et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 13 (2011)
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function
Brian Liau et al.
BIOMATERIALS (2011)
The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle
Sara Hinds et al.
BIOMATERIALS (2011)
Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform
Anupama Natarajan et al.
BIOMATERIALS (2011)
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
H. G. Laverty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture
Nathaniel L. Tulloch et al.
CIRCULATION RESEARCH (2011)
Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review
Carl-Fredrik Mandenius et al.
JOURNAL OF APPLIED TOXICOLOGY (2011)
Recurrent myocardial infarction associated with gefitinib therapy
Donald R. Lynch et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip
Anna Grosberg et al.
LAB ON A CHIP (2011)
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
Thomas Force et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Impact of high-throughput screening in biomedical research
Ricardo Macarron et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology
Sebastian Schaaf et al.
PLOS ONE (2011)
Micro Total Bioassay System for Ingested Substances: Assessment of Intestinal Absorption, Hepatic Metabolism, and Bioactivity
Yuki Imura et al.
ANALYTICAL CHEMISTRY (2010)
Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses
Daniel J. Maltman et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Development of a Drug Screening Platform Based on Engineered Heart Tissue
Arne Hansen et al.
CIRCULATION RESEARCH (2010)
Highly conductive, printable and stretchable composite films of carbon nanotubes and silver
Kyoung-Yong Chun et al.
NATURE NANOTECHNOLOGY (2010)
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Stefan R. Braam et al.
STEM CELL RESEARCH (2010)
High-Content Drug Screening with Engineered Musculoskeletal Tissues
Herman Vandenburgh
TISSUE ENGINEERING PART B-REVIEWS (2010)
Cardiotoxicity induced by tyrosine kinase inhibitors
George S. Orphanos et al.
ACTA ONCOLOGICA (2009)
Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative
Jonathan P. Piccini et al.
AMERICAN HEART JOURNAL (2009)
Characterization of a Gastrointestinal Tract Microscale Cell Culture Analog Used to Predict Drug Toxicity
Gretchen J. Mahler et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
Leo I. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Towards a human-on-chip: Culturing multiple cell types on a chip with compartmentalized microenvironments
Chi Zhang et al.
LAB ON A CHIP (2009)
A micro cell culture analog (μCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs
Jong Hwan Sung et al.
LAB ON A CHIP (2009)
In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Oren Caspi et al.
STEM CELLS AND DEVELOPMENT (2009)
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
M. L. Telli et al.
ANNALS OF ONCOLOGY (2008)
Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics
Ming Hui Chen et al.
CIRCULATION (2008)
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Manuela Schmidinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib
Brian B. Hasinoff et al.
MOLECULAR PHARMACOLOGY (2008)
An evaluation of the cardiotoxicity of imatinib mesylate
Antonio Luiz Ribeiro et al.
LEUKEMIA RESEARCH (2008)
Drug-screening platform based on the contractility of tissue-engineered muscle
Herman Vandenburgh et al.
MUSCLE & NERVE (2008)
Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload
Takahisa Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells
Yvonne Will et al.
TOXICOLOGICAL SCIENCES (2008)
Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature
Mao Xiang Chen et al.
BMC BIOTECHNOLOGY (2007)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma
M. Mego et al.
ANNALS OF ONCOLOGY (2007)
Muscular thin films for building actuators and powering devices
Adam W. Feinberg et al.
SCIENCE (2007)
Cardiotoxicity of trastuzumab in clinical practice
Heather L. McArthur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Thomas Force et al.
NATURE REVIEWS CANCER (2007)
Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts
Vadim V. Fedorov et al.
HEART RHYTHM (2007)
Arrhythmogenic ion-channel remodeling in the heart: Heart failure, myocardial infarction, and atrial fibrillation
Stanley Nattel et al.
PHYSIOLOGICAL REVIEWS (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkela et al.
NATURE MEDICINE (2006)
Akt1 is required for physiological cardiac growth
B DeBosch et al.
CIRCULATION (2006)
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31
E Tan-Chiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Real-time measurement of the contractile forces of self-organized cardiomyocytes on hybrid biopolymer microcantilevers
J Park et al.
ANALYTICAL CHEMISTRY (2005)
Tyrosine kinases as targets for cancer therapy
DS Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds
M Radisic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The emerging normal and disease-related roles of anaplastic lymphoma kinase
K Pulford et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia
S Salesse et al.
ONCOGENE (2002)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
C Özcelik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Glycogen synthase kinase-3β -: A novel regulator of cardiac hypertrophy and development
SE Hardt et al.
CIRCULATION RESEARCH (2002)
ErbB2 is essential in the prevention of dilated cardiomyopathy
SA Crone et al.
NATURE MEDICINE (2002)
Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel
AJ Moss et al.
CIRCULATION (2002)
Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers
HR Lu et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2001)
分享论文
